Abstract:Objective: To compare the expression of serum nucleosome and the antinucleosome antibody family [antinucleosome antibodies,anti-double-stranded DNA(anti-dsDNA) antibodies and antihistone antibodies] by enzyme-linked immunosorbent assay between the healthy controls and patients with systemic lupus erythematosus(SLE) to analye the relationship of the serum soluble nucleosome,the antinu-cleosome antibody family and the organ or system damage in SLE,and to define the role of apoptosis in the relationships.Methods:Seventy-six SLE inpatients were selected from two hospitals,and normal healthy volunteers were recruited as controls(n=69).General information and the data of organ or system damage were collected by self-designed questionnaire containing the Systemic Lupus International Collaborative Clinics/American College of Rheumatology Damage Index(SLICC/ACR DI).Annexin V(AV) and propidium iodide(PI) were used to detect the early apoptosis rate of peripheral blood mononuclear cells(PBMCs).Serum soluble nucleosome levels as well as antinucleosome antibodies,anti-double-stranded DNA antibodies,and antihistone antibodies activities were assessed by Sandwich-enzyme-linked immunosorbent assay(ELISA).Results:Higher levels of antinucleosome antibodies 95.826±94.084 IU/ml,anti-dsDNA antibodies 280.551±305.954 IU/ml and antihistone antibodies 58.557±66.833 IU/ml were found in SLE patients compared with those in normal healthy controls(10.106±0.5348 IU/ml,20.034±12.075 IU/ml,9.290±1.281 IU/ml,respectively).The levels of serum antinucleosome antibodies had a positive correlation with antihistone antibodies(r=0.852,t=13.985,P=0.000),anti-dsDNA antibodies(r=0.788,t=11.028,P=0.000),SLICC/ACR DI(rs=0.552,t=4.23,P=0.000),as well as the early apoptosis rate of PBMCs(r=0.341,t=3.404,P=0.001) in SLE.The levels of serum anti-dsDNA antibodies had a positive correlation with antihistone antibodies(r=0.797,t=11.358,P=0.000),SLICC/ACR DI(rs=0.428,t=3.86,P=0.000),as well as the early apoptosis rate of PBMCs(r=0.385,t=3.917,P=0.000) in SLE.The levels of serum antihistone antibodies had a positive correlation with SLICC/ACR DI(rs=0.390,t=3.74,P=0.000),as well as the early apoptosis rate of PBMCs(r=0.277,t=2.702,P=0.008) in SLE.Increased concentrations of serum soluble antinucleosome antibodies,anti-dsDNA antibodies and antihistone antibodies were found in SLE patients with proteinuria(n=62)(103.221±24.773 IU/ml,305.194±101.912 IU/ml,65.084±18.543 IU/ml,respectively) compared with those in SLE patients without proteinuria(n=14)(63.074±15.478 IU/ml,171.417±66.122 IU/ml,29.652±4.269 IU/ml,respectively)(t=5.796,P=0.0000,t=4.681,P=0.0000,t=3.680,P=0.0004,respectively).Conclusion:The expression of serum antinucleosome antibodies,anti-dsDNA antibodies,and antihistone antibodies are increased among patients with SLE,and the serum antinucleosome antibodies family levels have close relationship with the organ or system damage and the early apoptosis rate of PBMCs in SLE.High expression of serum antinucleosome antibodies family and high PBMCs apoptosis rate are likely to involve in the pathogenesis of SLE.Antinucleosome antibody family may be an important factor for renal involvement in this subgroup of patients with SLE.

Increased Granulocyte Heparanase Activity in Neutrophils from Patients with Lupus Nephritis and Idiopathic Membranous Nephropathy

Increased Urine Excretion of Neutrophil Granule Cargo in Active Proliferative Lupus Nephritis

Urinary biomarkers associated with pathogenic pathways reflecting histological findings in lupus nephritis

Heparanase Increases Podocyte Survival and Autophagic Flux after Adriamycin-Induced Injury

Urinary Biomarkers Associated With Pathogenic Pathways Reflecting Histologic Findings in Lupus Nephritis

Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells

Characteristics and Renal Survival of Patients with Lupus Nephritis with Glomerular Immunoglobulin G4 Deposition: a Single-Centre Retrospective Analysis.

Increased Urinary Interleukin 22 Binding Protein Levels Correlate with Lupus Nephritis Activity

Heparin-binding protein as a novel biomarker for sepsis-related acute kidney injury

Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis

Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses.

Plasma-soluble Urokinase-Type Plasminogen Activator Receptor Levels Are Associated with Clinical and Pathological Activities in Lupus Nephritis: a Large Cohort Study from China

Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients

Association of expression of serum antinucleosome antibody family with indices of the damage of organ or system in systemic lupus erythematosus

Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis

Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria

Human Neutrophil Peptide 1-3, A Component Of The Neutrophil Extracellular Trap, As A Potential Biomarker Of Lupus Nephritis

Serum Uric Acid Combined with Homocysteine as a Predictive Biomarker of Lupus Nephritis

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

Plasma Soluble Urokinase Receptor Level is Correlated with Podocytes Damage in Patients with IgA Nephropathy

Association of serum soluble nucleosome with damage of organ or system in patients with systemic lupus erythematosus